FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Kerwin

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Genes & Molecular Sequences

Alleles

Activities & Behaviors

Schizophrenic Psychology

Co-author Network

Publications

TOP 3
KJ Aitchison; Mary L Forsling; Patricia Huezo-Diaz; Robert W Kerwin; Evangelia M Tsapakis; Kim Wolff
Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT.
Kim Wolff; Mary L Forsling; Robert W Kerwin; Carmine M Pariante; Evangelia M Tsapakis; KJ Aitchison
Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption.
Pilar A Saiz; Margaret T Susce; Dan A Clark; Robert W Kerwin; Patricio Molero; Maria J Arranz; Jose de Leon
An investigation of the alpha1A-adrenergic receptor gene and antipsychotic-induced side-effects.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Kerwin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: KJ Aitchison; Mary L Forsling; Patricia Huezo-Diaz; Robert W Kerwin; Evangelia M Tsapakis; Kim Wolff
Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT.
Journal of psychopharmacology (Oxford, England) 2012;26(3):408-18.
2012: Kim Wolff; Mary L Forsling; Robert W Kerwin; Carmine M Pariante; Evangelia M Tsapakis; KJ Aitchison
Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption.
Journal of psychopharmacology (Oxford, England) 2012;26(3):419-28.
2008: Pilar A Saiz; Margaret T Susce; Dan A Clark; Robert W Kerwin; Patricio Molero; Maria J Arranz; Jose de Leon
An investigation of the alpha1A-adrenergic receptor gene and antipsychotic-induced side-effects.
Human psychopharmacology 2008;23(2):107-14.
2008: Jacqueline Compton; Michael J Travis; Ray Norbury; Kjell Erlandsson; Therese van Amelsvoort; Eileen Daly; Wendy Waddington; P Matthiasson; Jos L H Eersels; Malcolm Whitehead; Robert W Kerwin; Peter J Ell; Declan G M Murphy
Long-term estrogen therapy and 5-HT(2A) receptor binding in postmenopausal women; a single photon emission tomography (SPET) study.
Hormones and behavior 2008;53(1):61-8.
2007: Dalu Mancama; Ignacio Mata; Robert W Kerwin; Maria J Arranz
Choline acetyltransferase variants and their influence in schizophrenia and olanzapine response.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2007;144B(7):849-53.
2007: D A Clark; Ignacio Mata; Robert W Kerwin; J Munro; Maria J Arranz
No association between ADRA2A polymorphisms and schizophrenia.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2007;144B(3):341-3.
2006: Gerome Breen; Diana Prata; Sarah Osborne; Janet Munro; Maggie Sinclair; Tao Li; Susan Staddon; David Dempster; Ricardo Sainz Fuertes; Barbara Arroyo; Robert W Kerwin; David St Clair; David Collier
Association of the dysbindin gene with bipolar affective disorder.
The American journal of psychiatry 2006;163(9):1636-8.
2006: Dan A Clark; Dalu Mancama; Robert W Kerwin; Maria J Arranz
Expression of the alpha1A-adrenergic receptor in schizophrenia.
Neuroscience letters 2006;401(3):248-51.
2006: Richard A A Kanaan; Robert W Kerwin
Lithium and clozapine rechallenge: a retrospective case analysis.
The Journal of clinical psychiatry 2006;67(5):756-60.
2005: Simon J C Davies; Smita A Pandit; Adrian Feeney; Brian J Stevenson; Robert W Kerwin; David J Nutt; E Jane Marshall; Stephen Boddington; Anne Lingford-Hughes
Is there cognitive impairment in clinically 'healthy' abstinent alcohol dependence?
Alcohol and alcoholism (Oxford, Oxfordshire) 2005;40(6):498-503.
2005: Dan A Clark; Maria J Arranz; Ignacio Mata; Jose Lopéz-Ilundain; Fernando Pérez-Nievas; Robert W Kerwin
Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/schizoaffective disorder in a Spanish isolate population.
Biological psychiatry 2005;58(6):435-9.
2005: Ingvar T Bjarnason; Inguar T Bjarnason; André Charlett; R John Dobbs; Sylvia M Dobbs; Mohammad A A Ibrahim; Robert W Kerwin; Robert F Mahler; Norman L Oxlade; Dale W Peterson; J Malcolm Plant; Ashley B Price; Clive Weller
Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-blind, placebo-controlled efficacy study.
Helicobacter 2005;10(4):276-87.
2005: R John Dobbs; Sylvia M Dobbs; Clive Weller; Ingvar T Bjarnason; Ingua T Bjarnason; Norman L Oxlade; André Charlett; Mazin A Al-Janabi; Robert W Kerwin; Robert F Mahler; Ashley B Price
Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 1: eradication of Helicobacter in the cachexia of idiopathic parkinsonism.
Helicobacter 2005;10(4):267-75.
2005: Simon Surguladze; Anita Patel; Robert W Kerwin; Martin Knapp; Michael J Travis
Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study.
Progress in neuro-psychopharmacology & biological psychiatry 2005;29(4):517-22.
2005: Susan Staddon; Maria J Arranz; Dalu Mancama; Fernando Perez-Nievas; Iñaki Arrizabalaga; Richard Anney; Paul Buckland; Amanda Elkin; Sarah Osborne; Janet Munro; Ignacio Mata; Robert W Kerwin
Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population.
Schizophrenia research 2005;73(1):49-54.
2005: Anusha A Bolonna; Robert W Kerwin
Partial agonism and schizophrenia.
The British journal of psychiatry : the journal of mental science 2005;186():7-10.
2004: Carmine M Pariante; Andrew S Papadopoulos; Lucia Poon; Anthony J Cleare; Stuart A Checkley; Judie English; Robert W Kerwin; Stafford Lightman
Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers.
Psychopharmacology 2004;177(1-2):200-6.
2004: Anusha A Bolonna; Maria J Arranz; Dalu Mancama; Robert W Kerwin
Pharmacogenomics--can genetics help in the care of psychiatric patients?
International review of psychiatry (Abingdon, England) 2004;16(4):311-9.
2004: Michael J Parsons; Ursula M D'Souza; Maria J Arranz; Robert W Kerwin; Andrew Makoff
The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity.
Biological psychiatry 2004;56(6):406-10.
2004: Carmine M Pariante; Sarah A Thomas; Simon Lovestone; Andrew Makoff; Robert W Kerwin
Do antidepressants regulate how cortisol affects the brain?
Psychoneuroendocrinology 2004;29(4):423-47.
2004: Ignacio Mata; Maria J Arranz; Ana Patiño; T Lai; M Beperet; Luis Sierrasesumaga; D Clark; Fernando Perez-Nievas; L Richards; F Ortuño; P Sham; Robert W Kerwin
Serotonergic polymorphisms and psychotic disorders in populations from North Spain.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2004;126B(1):88-94.
2004: Robert W Kerwin; Anusha A Bolonna
Is clozapine antisuicidal?
Expert review of neurotherapeutics 2004;4(2):187-90.
2004: Robert W Kerwin; Sarah Osborne; Ricardo Sainz Fuertes
Heat stroke in schizophrenia during clozapine treatment: rapid recognition and management.
Journal of psychopharmacology (Oxford, England) 2004;18(1):121-3.
2004: Patricia Huezo-Diaz; Maria J Arranz; Janet Munro; Sarah Osborne; Andrew Makoff; Robert W Kerwin; J Austin; M O'Donovan
An association study of the neurotensin receptor gene with schizophrenia and clozapine response.
Schizophrenia research 2004;66(2-3):193-5.
2003: Dalu Mancama; Maria J Arranz; Robert W Kerwin
Pharmacogenomics of psychiatric drug treatment.
Current opinion in molecular therapeutics 2003;5(6):642-9.
2003: Carmine M Pariante; Abdul Hye; Ritchie Williamson; Andrew Makoff; Simon Lovestone; Robert W Kerwin
The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(9):1553-61.
2003: Carmine M Pariante; Richard B Kim; Andrew Makoff; Robert W Kerwin
Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters.
British journal of pharmacology 2003;139(6):1111-8.
2003: Emanuela Mundo; S Tharmalingham; Maria Neves-Pereira; E J Dalton; Fabio Macciardi; sagar parikh; Anusha A Bolonna; Robert W Kerwin; Maria J Arranz; Andrew Makoff; James L Kennedy
Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder.
Molecular psychiatry 2003;8(2):241-5.
2003: Robert W Kerwin
A perspective on progress in pharmacogenomics.
American journal of pharmacogenomics : genomics-related research in drug development and clinical practice 2003;3(6):371-3.
2003: Dalu Mancama; Robert W Kerwin
Role of pharmacogenomics in individualising treatment with SSRIs.
CNS drugs 2003;17(3):143-51.
2002: Blanca Gutiérrez; Maria J Arranz; Patricia Huezo-Diaz; David Dempster; P Matthiasson; Michael J Travis; Janet Munro; Sarah Osborne; Robert W Kerwin
Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response.
Schizophrenia research 2002;58(1):93-7.
2002: Simon Z East; Philip W J Burnet; Robert W Kerwin; Paul J Harrison
An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia.
Schizophrenia research 2002;57(1):15-26.
2002: Susan Staddon; Maria J Arranz; Dalu Mancama; Ignacio Mata; Robert W Kerwin
Clinical applications of pharmacogenetics in psychiatry.
Psychopharmacology 2002;162(1):18-23.
2002: Carmine M Pariante; Andrew S Papadopoulos; Lucia Poon; Stuart A Checkley; Judie English; Robert W Kerwin; Stafford Lightman
A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis.
Biological psychiatry 2002;51(11):922-30.
2002: Dalu Mancama; Maria J Arranz; Robert W Kerwin
Genetic predictors of therapeutic response to clozapine: current status of research.
CNS drugs 2002;16(5):317-24.
2001: Carmine M Pariante; Andrew Makoff; Simon Lovestone; S Feroli; A Heyden; Andrew H Miller; Robert W Kerwin
Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters.
British journal of pharmacology 2001;134(6):1335-43.
2001: Robert W Kerwin; Dalu Mancama; Maria J Arranz
Genetic strategies for the personalization of antipsychotic treatment.
Expert review of molecular diagnostics 2001;1(3):275-80.
2001: Monsheel Sodhi; Philip W J Burnet; A J Makoff; Robert W Kerwin; Paul J Harrison
RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia.
Molecular psychiatry 2001;6(4):373-9.
2001: Maria J Arranz; Janet Munro; Sarah Osborne; David Collier; Robert W Kerwin
Applications of pharmacogenetics in psychiatry: personalisation of treatment.
Expert opinion on pharmacotherapy 2001;2(4):537-42.
2001: Anusha A Bolonna; Robert W Kerwin; Janet Munro; Maria J Arranz; Andrew Makoff
Polymorphisms in the genes for mGluR types 7 and 8: association studies with schizophrenia.
Schizophrenia research 2001;47(1):99-103.
2001: Maria J Arranz; David Collier; Robert W Kerwin
Pharmacogenetics for the individualization of psychiatric treatment.
American journal of pharmacogenomics : genomics-related research in drug development and clinical practice 2001;1(1):3-10.
2001: Maria J Arranz; Dalu Mancama; Robert W Kerwin
Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)).
International journal of molecular medicine 2001;7(1):27-30.
2000: KJ Aitchison; Frank J Gonzalez; L C Quattrochi; A Sapone; J H Zhao; H Zaher; Guillermo Elizondo; C Bryant; Janet Munro; David A Collier; A I Makoffa; Robert W Kerwin
Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance.
Pharmacogenetics 2000;10(8):695-704.
2000: C M Stephenson; V Bigliani; Hugh M Jones; Rachel S Mulligan; PD Acton; D Visvikis; Peter J Ell; Robert W Kerwin; Lyn S Pilowsky
Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography(SPET) study.
The British journal of psychiatry : the journal of mental science 2000;177():408-15.
2000: Maria J Arranz; J Munro; Sarah Osborne; David Collier; Robert W Kerwin
Difficulties in replication of results.
Lancet 2000;356(9238):1359-60.
2000: Anne Lingford-Hughes; PD Acton; Svetislav Gacinovic; Stephen Boddington; Durval C Costa; Lyn S Pilowsky; Peter J Ell; E Jane Marshall; Robert W Kerwin
Levels of gamma-aminobutyric acid-benzodiazepine receptors in abstinent, alcohol-dependent women: preliminary findings from an 123I-iomazenil single photon emission tomography study.
Alcoholism, clinical and experimental research 2000;24(9):1449-55.
2000: J T Birkett; Maria J Arranz; Janet Munro; S Osbourn; Robert W Kerwin; David A Collier
Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response.
Neuroreport 2000;11(9):2017-20.
2000: V Bigliani; Rachel S Mulligan; PD Acton; Ruth Ohlsen; Victor W Pike; Peter J Ell; Svetislav Gacinovic; Robert W Kerwin; Lyn S Pilowsky
Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study.
Psychopharmacology 2000;150(2):132-40.
2000: Maria J Arranz; Janet Munro; J Birkett; Anusha A Bolonna; Dalu Mancama; Monsheel Sodhi; K P Lesch; J F Meyer; Pak Sham; David A Collier; R M Murray; Robert W Kerwin
Pharmacogenetic prediction of clozapine response.
Lancet 2000;355(9215):1615-6.
2000: Maria J Arranz; Anusha A Bolonna; Janet Munro; C J Curtis; David A Collier; Robert W Kerwin
The serotonin transporter and clozapine response.
Molecular psychiatry 2000;5(2):124-5.
2000: Maria J Arranz; Robert W Kerwin
Neurotransmitter-related genes and antipsychotic response: pharmacogenetics meets psychiatric treatment.
Annals of medicine 2000;32(2):128-33.
2000: Anusha A Bolonna; Maria J Arranz; Janet Munro; Sarah Osborne; M Petouni; M Martinez; Robert W Kerwin
No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response.
Neuroscience letters 2000;280(1):65-8.
2000: KJ Aitchison; Michael W Jann; J H Zhao; T Sakai; H Zaher; Kim Wolff; David A Collier; Robert W Kerwin; Frank J Gonzalez
Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice.
Journal of psychopharmacology (Oxford, England) 2000;14(4):353-9.
2000: Hugh M Jones; Michael J Travis; Rachel Mulligan; D Visvikis; Svetislav Gacinovic; Peter J Ell; Robert W Kerwin; Lyn S Pilowsky
In vivo serotonin 5-HT(2A) receptor occupancy and quetiapine.
The American journal of psychiatry 2000;157(1):148.
1999: V Bigliani; Rachel S Mulligan; PD Acton; D Visvikis; Peter J Ell; C Stephenson; Robert W Kerwin; Lyn S Pilowsky
In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugs. [123I]epidepride single photon emission tomography (SPET) study.
The British journal of psychiatry : the journal of mental science 1999;175():231-8.
1999: KJ Aitchison; Janet Munro; P Wright; S Smith; Andrew Makoff; C Sachse; Pak C Sham; Robin M Murray; David A Collier; Robert W Kerwin
Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation.
British journal of clinical pharmacology 1999;48(3):388-94.
1998: Maria J Arranz; T Li; Janet Munro; X Liu; R Murray; D A Collier; Robert W Kerwin
Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response.
Pharmacogenetics 1998;8(6):481-4.
1998: Michael J Travis; GF Busatto; Lyn S Pilowsky; Rachel Mulligan; PD Acton; Svetislav Gacinovic; J Mertens; D Terrière; Durval C Costa; Peter J Ell; Robert W Kerwin
5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150.
The British journal of psychiatry : the journal of mental science 1998;173():236-41.
1998: Anne Lingford-Hughes; PD Acton; Svetislav Gacinovic; John Suckling; GF Busatto; Stephen Boddington; Ed Bullmore; Peter W R Woodruff; Durval C Costa; Lyn S Pilowsky; Peter J Ell; E Jane Marshall; Robert W Kerwin
Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy.
The British journal of psychiatry : the journal of mental science 1998;173():116-22.
1998: Maria J Arranz; Janet Munro; Pak Sham; G Kirov; Robin M Murray; David A Collier; Robert W Kerwin
Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response.
Schizophrenia research 1998;32(2):93-9.
1998: T Li; Maria J Arranz; KJ Aitchison; C Bryant; X Liu; Robert W Kerwin; R Murray; P Sham; David A Collier
Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia.
Schizophrenia research 1998;32(2):87-92.
1998: Maria J Arranz; Janet Munro; Michael J Owen; Gillian Spurlock; Pak C Sham; J Zhao; G Kirov; David A Collier; Robert W Kerwin
Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine.
Molecular psychiatry 1998;3(1):61-6.
1997: Robert W Kerwin; KJ Aitchison
Cost-effectiveness of clozapine.
The British journal of psychiatry : the journal of mental science 1997;171():584.
1997: JV Lucey; C E Burness; Durval C Costa; Svetislav Gacinovic; Lyn S Pilowsky; Peter J Ell; IM Marks; Robert W Kerwin
Wisconsin Card Sorting Task (WCST) errors and cerebral blood flow in obsessive-compulsive disorder (OCD).
The British journal of medical psychology 1997;70 ( Pt 4)():403-11.
1997: J Mulcrone; Robert W Kerwin
The regional pattern of D4 gene expression in human brain.
Neuroscience letters 1997;234(2-3):147-50.
1997: JV Lucey; Durval C Costa; G Adshead; M Deahl; GF Busatto; Svetislav Gacinovic; Michael J Travis; Lyn S Pilowsky; Peter J Ell; IM Marks; Robert W Kerwin
Brain blood flow in anxiety disorders. OCD, panic disorder with agoraphobia, and post-traumatic stress disorder on 99mTcHMPAO single photon emission tomography (SPET).
The British journal of psychiatry : the journal of mental science 1997;171():346-50.
1997: Michael J Travis; GF Busatto; Lyn S Pilowsky; Robert W Kerwin; Rachel Mulligan; Svetislav Gacinovic; Durval C Costa; Peter J Ell; J Mertens; D Terriere
Serotonin: 5-HT2A receptor occupancy in vivo and response to the new antipsychotics olanzapine and sertindole.
The British journal of psychiatry : the journal of mental science 1997;171():290-1.
1997: Lyn S Pilowsky; Rachel S Mulligan; PD Acton; Peter J Ell; D C Costa; Robert W Kerwin
Limbic selectivity of clozapine.
Lancet 1997;350(9076):490-1.
1997: KJ Aitchison; Robert W Kerwin
Cost-effectiveness of clozapine. A UK clinic-based study.
The British journal of psychiatry : the journal of mental science 1997;171():125-30.
1997: JV Lucey; Durval C Costa; GF Busatto; Lyn S Pilowsky; IM Marks; Peter J Ell; Robert W Kerwin
Caudate regional cerebral blood flow in obsessive-compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography.
Psychiatry research 1997;74(1):25-33.
1997: GF Busatto; Lyn S Pilowsky; Durval C Costa; J Mertens; D Terriere; Peter J Ell; Rachel Mulligan; Michael J Travis; J E Leysen; Dominic Lui; Svetislav Gacinovic; Wendy Waddington; Anne Lingford-Hughes; Robert W Kerwin
Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects.
European journal of nuclear medicine 1997;24(2):119-24.
1997: G F Busatto; Robert W Kerwin
Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia.
Journal of psychopharmacology (Oxford, England) 1997;11(1):3-12.
1997: GF Busatto; Lyn S Pilowsky; Durval C Costa; Peter J Ell; Anthony David; J V Lucey; Robert W Kerwin
Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia.
The American journal of psychiatry 1997;154(1):56-63.
1996: J Mulcrone; Robert W Kerwin
No difference in the expression of the D4 gene in post-mortem frontal cortex from controls and schizophrenics.
Neuroscience letters 1996;219(3):163-6.
1996: S Shaikh; D A Collier; Pak C Sham; D Ball; KJ Aitchison; Homero Vallada; I Smith; M Gill; Robert W Kerwin
Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia.
Human genetics 1996;97(6):714-9.
1996: Lyn S Pilowsky; GF Busatto; M Taylor; Durval C Costa; T Sharma; T Sigmundsson; Peter J Ell; V Nohria; Robert W Kerwin
Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.
Psychopharmacology 1996;124(1-2):148-53.
1995: Monsheel Sodhi; Maria J Arranz; D Curtis; D M Ball; Pak Sham; G W Roberts; J Price; D A Collier; Robert W Kerwin
Association between clozapine response and allelic variation in the 5-HT2C receptor gene.
Neuroreport 1995;7(1):169-72.
1995: GF Busatto; Anthony David; Durval C Costa; Peter J Ell; Lyn S Pilowsky; J V Lucey; Robert W Kerwin
Schizophrenic auditory hallucinations are associated with increased regional cerebral blood flow during verbal memory activation in a study using single photon emission computed tomography.
Psychiatry research 1995;61(4):255-64.
1995: J V Lucey; Durval C Costa; T Blanes; GF Busatto; Lyn S Pilowsky; N Takei; Isaac M Marks; Peter J Ell; Robert W Kerwin
Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions.
The British journal of psychiatry : the journal of mental science 1995;167(5):629-34.
1995: Nicola S Gray; Lyn S Pilowsky; Jeffrey A Gray; Robert W Kerwin
Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET.
Schizophrenia research 1995;17(1):95-107.
1995: Robert W Kerwin; Lyn S Pilowsky
Traditional receptor theory and its application to neuroreceptor measurements in functional imaging.
European journal of nuclear medicine 1995;22(7):699-710.
1995: Robert W Kerwin
Clozapine: back to the future for schizophrenia research.
Lancet 1995;345(8957):1063-4.
1995: GF Busatto; Lyn S Pilowsky; Durval C Costa; Peter J Ell; Anne Lingford-Hughes; Robert W Kerwin
In vivo imaging of GABAA receptors using sequential whole-volume iodine-123 iomazenil single-photon emission tomography.
European journal of nuclear medicine 1995;22(1):12-6.
1995: GF Busatto; Lyn S Pilowsky; Durval C Costa; Peter J Ell; Nicolaas P L G Verhoeff; Robert W Kerwin
Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.
Psychopharmacology 1995;117(1):55-61.
1994: Robert W Kerwin; Lyn S Pilowsky; J Munro; S Shaikh; M Gill; David Collier
Functional neuroimaging and pharmacogenetic studies of clozapine's action at dopamine receptors.
The Journal of clinical psychiatry 1994;55 Suppl B():57-62.
1994: GF Busatto; Durval C Costa; Peter J Ell; Lyn S Pilowsky; Anthony David; Robert W Kerwin
Regional cerebral blood flow (rCBF) in schizophrenia during verbal memory activation: a 99mTc-HMPAO single photon emission tomography (SPET) study.
Psychological medicine 1994;24(2):463-72.
1994: B M Pedro; Lyn S Pilowsky; Durval C Costa; David R Hemsley; Peter J Ell; Nicolaas P L G Verhoeff; Robert W Kerwin; Nicola S Gray
Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia.
Psychological medicine 1994;24(2):423-9.
1994: Lyn S Pilowsky; Durval C Costa; Peter J Ell; Nicolaas P L G Verhoeff; Robin M Murray; Robert W Kerwin
D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study.
The British journal of psychiatry : the journal of mental science 1994;164(1):16-26.
1993: GF Busatto; Lyn S Pilowsky; Peter J Ell; Durval C Costa; Nicolaas P L G Verhoeff; Robert W Kerwin
Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone.
The British journal of psychiatry : the journal of mental science 1993;163():833-4.
1993: Lyn S Pilowsky; Durval C Costa; Peter J Ell; Robin M Murray; Nicolaas P L G Verhoeff; Robert W Kerwin
Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study.
Psychological medicine 1993;23(3):791-7.
1993: S Shaikh; David Collier; Robert W Kerwin; Lyn S Pilowsky; M Gill; W M Xu; A Thornton
Dopamine D4 receptor subtypes and response to clozapine.
Lancet 1993;341(8837):116.
1992: Robert W Kerwin; L S Pilowsky; A Revely; Ian Everall; J Bearn; M Launer
Clozapine.
The British journal of psychiatry : the journal of mental science 1992;161():862-3.
1992: Lyn S Pilowsky; Durval C Costa; Peter J Ell; Robin M Murray; Nicolaas P L G Verhoeff; Robert W Kerwin
Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia.
Lancet 1992;340(8813):199-202.